A. Bartoli et al., A RAPID AND SPECIFIC ASSAY FOR THE DETERMINATION OF LAMOTRIGINE IN HUMAN PLASMA BY NORMAL-PHASE HPLC, Therapeutic drug monitoring, 19(1), 1997, pp. 100-107
A rapid and specific high-performance liquid chromatography assay of l
amotrigine in human plasma is described. Lamotrigine is extracted with
dichloromethane from buffered plasma to which an internal standard ha
s been added. The solvent is directly injected into a 250 x 4.6-mm Sph
erisorb Silica column and the drug is eluted by using a mixture of met
hanol, n-heptane, dichloromethane, and 28-30% ammonium hydroxide (20:4
0:40:0.3 vol/vol) at a flow rate of 1 ml/min. The eluates are detected
at 240 nm. The assay requires 250 mu l of sample, and concentrations
as low as 0.4 mu g/ml can be measured accurately. The method is linear
in the range of 0.4-16 mu g/ml, with a mean coefficient of correlatio
n (r) greater than or equal to 0.997. Within-and between-day relative
standard deviations at three different concentration levels (1, 4, and
8 mu g/ml) are less than or equal to 8.6%.